Establishment Labs Holdings Inc. reports results for the quarter ended September 30 - Earnings Summary
Establishment Labs Holdings Inc. reported a quarterly adjusted loss of 31 cents per share for the quarter ended September 30, higher than the same quarter last year, when the company reported EPS of -38 cents. The mean expectation of ten analysts for the quarter was for a loss of 26 cents per share. Wall Street expected results to range from -32 cents to -20 cents per share.
Revenue rose 33.9% to $71.99 million from a year ago; analysts expected $66.46 million.
Establishment Labs Holdings Inc.'s reported EPS for the quarter was a loss of 35 cents.
The company reported a quarterly loss of $10.71 million.
Establishment Labs Holdings Inc. shares had risen by 7.5% this quarter and lost 5.4% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had risen by about 9% in the last three months.
In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
The current average analyst rating on the shares is "strong buy" and the breakdown of recommendations is 10 "strong buy" or "buy," no "hold" and no "sell" or "strong sell." The average consensus recommendation for the medical equipment, supplies & distribution peer group is "buy."
This summary was machine generated from LSEG data October 29 at 06:01 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING | ESTIMATE | ACTUAL | BEAT, MET, MISSED |
Sep. 30 2026 | -0.26 | -0.31 | Missed |
Jun. 30 2026 | -0.34 | -0.33 | Beat |
Mar. 31 2026 | -0.35 | -0.45 | Missed |
Dec. 31 2025 | -0.22 | -0.09 | Beat |